GlassScriptPhysician profile
Stacey M Sullivan
NPI 1144597816
$7,009.11
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,281 · 2022: $1,305 · 2023: $1,303 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,728.53 | 2021-2023 | Invega Trinza, Invega Sustenna |
| Abbvie INC. | $805.99 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $559.91 | 2021-2023 | Austedo, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $552.65 | 2021-2025 | Caplyta |
| Alkermes, INC. | $536.76 | 2021-2023 | Lybalvi, Aristada, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $420.83 | 2021-2023 | Rexulti, Abilify Maintena |
| Lundbeck LLC | $260.23 | 2021-2023 | Abilify Maintena, Rexulti |
| Sunovion Pharmaceuticals INC. | $237.76 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.93 | 2021-2023 | Trintellix |
| Corium, LLC | $145.15 | 2021-2023 | Azstarys |
| Neurocrine Biosciences, INC. | $109.80 | 2021-2023 | Ingrezza |
| Biogen, INC. | $87.36 | 2023 | |
| Noven Therapeutics, LLC | $82.43 | 2022-2023 | Xelstrym, Secuado |
| Bausch Health US, LLC | $80.54 | 2021-2023 | Aplenzin, Wellbutrin |
| Jazz Pharmaceuticals INC. | $78.24 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $39.89 | 2021-2023 | Jornay Pm |
| Axsome Therapeutics, INC. | $32.98 | 2022-2023 | Auvelity |
| Almatica Pharma LLC | $17.16 | 2022 | |
| Alfasigma USA, INC. | $16.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.